(Q34204718)

English

Risk factors associated with cognitive decline in the elderly with type 2 diabetes: baseline data analysis of the Japanese Elderly Diabetes Intervention Trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 July 2017

Risk factors associated with cognitive decline in the elderly with type 2 diabetes: baseline data analysis of the Japanese Elderly Diabetes Intervention Trial (English)

1 reference

Europe PubMed Central

31 July 2017

0 references

type 2 diabetes

0 references

author name string

Hiroyuki Umegaki

1

1 reference

Europe PubMed Central

31 July 2017

Satoshi Iimuro

2

1 reference

Europe PubMed Central

31 July 2017

Tomohiro Shinozaki

3

1 reference

Europe PubMed Central

31 July 2017

Atsushi Araki

4

1 reference

Europe PubMed Central

31 July 2017

Takashi Sakurai

5

1 reference

Europe PubMed Central

31 July 2017

Katsuya Iijima

6

1 reference

Europe PubMed Central

31 July 2017

Yasuo Ohashi

7

1 reference

Europe PubMed Central

31 July 2017

Hideki Ito

8

1 reference

Europe PubMed Central

31 July 2017

Japanese Elderly Diabetes Intervention Trial Study Group

9

1 reference

Europe PubMed Central

31 July 2017

publication date

1 April 2012

1 reference

Europe PubMed Central

31 July 2017

Geriatrics and Gerontology International

1 reference

Europe PubMed Central

31 July 2017

12 Suppl 1

1 reference

Europe PubMed Central

31 July 2017

103-109

1 reference

Europe PubMed Central

31 July 2017

Type 2 diabetes mellitus, cognitive impairment and dementia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Long-term effect of diabetes and its treatment on cognitive function.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Improving metabolic control leads to better working memory in adults with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Postprandial plasma glucose excursions and cognitive functioning in aged type 2 diabetics.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

The age-dependent relation of blood pressure to cognitive function and dementia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Blood pressure, cognitive functions, and prevention of dementias in older patients with hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Serum lipids and memory in a population based cohort of middle age women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Retinal microvascular abnormalities and cognitive decline: the ARIC 14-year follow-up study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Retinal microvascular signs and cognitive impairment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Predictors of cognitive decline in older individuals with diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Standards of medical care in diabetes--2007.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Cerebrospinal fluid beta-amyloid 1-42 concentration may predict cognitive decline in older women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Albuminuria and decline in cognitive function: The ONTARGET/TRANSCEND studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Microalbuminuria is a risk factor for cerebral small vessel disease in community-based elderly subjects.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Subcortical ischaemic vascular dementia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Factors associated with cognitive impairment in elderly patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Alzheimer's disease and endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Diabetes, cognitive function, and the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Hypertension and cerebrovascular damage

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Why are strokes related to hypertension? Classic studies and hypotheses revisited

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Hemodynamic consequences of deformed microvessels in the brain in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Neurovascular regulation in the normal brain and in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Hypertension and cerebrovascular dysfunction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Triglyceride levels affect cognitive function in noninsulin-dependent diabetics.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Association between high-density lipoprotein and cognitive impairment in the oldest old.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Statins and the risk of dementia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00817.X

21 January 2018

Identifiers

10.1111/J.1447-0594.2011.00817.X

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34204718&oldid=1542951571"